Last reviewed · How we verify

NCT04484571

Multimodal Instrumented Assessment of Post-stroke Elbow

Status unknown NA Last updated 25 July 2023
What this trial tests

NA trial testing Neuroexsos elbow module in Spasticity, Muscle in 60 participants. Status unknown.

Timeline
6 July 2020
Primary endpoint
30 May 2024
30 July 2024

Quick facts

Lead sponsorAzienda USL Toscana Nord Ovest
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment60
Start date6 July 2020
Primary completion30 May 2024
Estimated completion30 July 2024
Sites1 location across Italy

Drugs / interventions tested

Conditions studied

Sponsor

Azienda USL Toscana Nord Ovest — full company profile →

Who can join

Adults 18 to 80, any sex, with Spasticity, Muscle or Stroke. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The proposed clinical trial will employ the NEUROExos Elbow Module (NEEM), an active robotic exoskeleton, for the passive mobilization and active training of elbow flexion and extension in 60 sub-acute and chronic stroke patients with motor impairments (hemiparesis and/or spasticity) of the right arm. The study protocol is a randomized controlled trial consisting of a 4-week functional rehabilitation program, with both clinical and robotically instrumented assessments to be conducted at baseline and post-treatment.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Robotic Rehabilitation and Multimodal Instrumented Assessment of Post-stroke Elbow Motor Functions-A Randomized Controlled Trial Protocol.
    Pilla A, Trigili E, McKinney Z, Fanciullacci C, et al · · 2020 · cited 11× · PMID 33193052 · DOI 10.3389/fneur.2020.587293

Verify or expand the search:

Other recruiting trials for Spasticity, Muscle

Currently open trials in the same condition.

Other Azienda USL Toscana Nord Ovest trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04484571.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing